Supplements sold on Amazon recalled by FDA due to contamination with other drugs
The U.S. Food and Drug Administration announced a recall of Umary supplements due to a contamination of two over-the-counter ...
US FDA approves BridgeBio's drug for rare heart condition
The U.S. Food and Drug Administration has approved BridgeBio's drug for a rare and deadly heart condition, the company said ...
Are food recalls and outbreaks on the rise? FDA says U.S. food supply still "one of the safest in the world"
The FDA says America's food supply is still "one of the safest in the world," despite some recent high-profile recalls and ...
FDA launches communications pilot to enhance medical device recall programme
The pilot by the FDA’s CDRH will improve communications about corrective actions being taken over certain medical device ...
Trump picks Dr. Marty Makary as Food and Drug Administration commissioner
President-elect Trump announced on Friday that he is nominating Dr. Marty Makary, a Johns Hopkins School of Medicine ...
Austin American-Statesman2h
Trump picks Johns Hopkins' Martin Makary as FDA commissioner
President-elect Donald Trump announced Friday that he has picked Dr. Martin Makary, a Johns Hopkins surgeon as Food and ...
Trump names his picks for FDA, CDC and surgeon general
Trump, 78, nominated Dr. Marty Makary – a professor at the Johns Hopkins School of Medicine – to serve as FDA commissioner; ...
Trump picks Marty Makary to lead FDA, Dave Weldon to run CDC
Makary and Weldon, who have criticized the agencies they may soon run, were joined by Janette Nesheiwat, Trump’s pick to be ...
Trump nominates Marty Makary, a critic of some COVID-19 health measures, to lead the FDA
President-elect Donald Trump has nominated a critic of COVID-19 health measures to lead the Food and Drug Administration ...
Trump's FDA pick is surgeon and writer Martin Makary
U.S. president-elect Donald Trump has nominated surgeon and writer Martin Makary to lead the Food and Drug Administration, ...
While legalizing marijuana is in limbo, FDA clears a PTSD study that could boost cannabis stocks over time
The move marks a rare action by the FDA to sanction a study on cannabis despite the plant’s current Schedule I classification ...